title: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance.
abstract: The expression of NF-kappaB was studied in freshly isolated peripheral blood mononuclear cells (PBMC) of patients with severe sepsis and major trauma. The expression of p65p50 heterodimer, the active form of NF-kappaB, was significantly reduced for all patients as compared with control subjects. The p50p50 homodimer, an inhibitory form of NF-kappaB, was reduced in the survivors of sepsis and in patients with trauma. Subsequent in vitro stimulation of PBMC with lipopolysaccharide (LPS) did not induce further NF-kappaB nuclear translocation: the survivors of sepsis and trauma patients showed low expression of both p65p50 and p50p50, whereas nonsurvivors of sepsis showed a predominance of the inactive homodimer and a low p65p50/p50p50 ratio when compared with control subjects. In the later group of patients there was a reverse correlation between plasma IL-10 levels and the p65p50/p50p50 ratio after in vitro LPS stimulation (r = -0.8, p = 0.04). The reduced expression of nuclear NF-kappaB was not due to its inhibition by IkappaBalpha, as very low expression of IkappaBalpha, as well as low levels of p65 and p50 were found in the cytoplasm of PBMC from patients with sepsis and trauma when compared with control subjects. These results demonstrate that upon LPS activation, PBMC of patients with systemic inflammatory response syndrome show patterns of NF-kappaB expression that resemble those reported during LPS tolerance: global down-regulation of NF-kappaB in survivors of sepsis and trauma patients and the presence of large amounts of the inactive homodimer in the nonsurvivors of sepsis.
authors.affiliation: Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Adib-Conquy
authors.forename: C
authors.initials: C
authors.lastname: Adrie
authors.forename: P
authors.initials: P
authors.lastname: Moine
authors.forename: K
authors.initials: K
authors.lastname: Asehnoune
authors.forename: C
authors.initials: C
authors.lastname: Fitting
authors.forename: M R
authors.initials: MR
authors.lastname: Pinsky
authors.forename: J F
authors.initials: JF
authors.lastname: Dhainaut
authors.forename: J M
authors.initials: JM
authors.lastname: Cavaillon
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015153:Blotting, Western; D002467:Cell Nucleus / Q000737:chemistry; D003593:Cytoplasm / Q000737:chemistry; D004586:Electrophoresis; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D016753:Interleukin-10 / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000032:analysis / Q000378:metabolism*; D052002:NF-kappa B p50 Subunit; D018805:Sepsis / Q000097:blood*; D051996:Transcription Factor RelA; D014947:Wounds and Injuries / Q000097:blood
chemical_list: D008070:Lipopolysaccharides; D016328:NF-kappa B; D052002:NF-kappa B p50 Subunit; D051996:Transcription Factor RelA; D016753:Interleukin-10